These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22198696)

  • 1. Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells.
    Song JX; Cao WL; Li FQ; Shi LN; Jia X
    Med Oncol; 2012 Dec; 29(4):2923-31. PubMed ID: 22198696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.
    Song JX; Li FQ; Cao WL; Jia X; Shi LN; Lu JF; Ma CF; Kong QQ
    Target Oncol; 2014 Sep; 9(3):263-72. PubMed ID: 23943313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and characterization of the monoclonal antibody against human sperm protein 17].
    Li FQ; Yang AL; Miao JW; Zhang CH; Wu B; Zhang XH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):638-40. PubMed ID: 16948914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sperm protein 17 is highly expressed in endometrial and cervical cancers.
    Li FQ; Liu Q; Han YL; Wu B; Yin HL
    BMC Cancer; 2010 Aug; 10():429. PubMed ID: 20712874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.
    Zhang M; Qian J; Lan Y; Lu Y; Li H; Hong B; Zheng Y; He J; Yang J; Yi Q
    Int J Cancer; 2014 Sep; 135(5):1132-41. PubMed ID: 24474467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vaccine for ovarian carcinoma targeting sperm protein 17.
    Chiriva-Internati M; Wang Z; Salati E; Timmins P; Lim SH
    Cancer; 2002 May; 94(9):2447-53. PubMed ID: 12015770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers.
    Suzuki M; Kato-Nakano M; Kawamoto S; Furuya A; Abe Y; Misaka H; Kimoto N; Nakamura K; Ohta S; Ando H
    Cancer Sci; 2009 Sep; 100(9):1623-30. PubMed ID: 19555390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system.
    Li FQ; Zhang SX; An LX; Gu YQ
    J Exp Clin Cancer Res; 2011 Mar; 30(1):25. PubMed ID: 21366930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma.
    Chiriva-Internati M; Wang Z; Salati E; Bumm K; Barlogie B; Lim SH
    Blood; 2002 Aug; 100(3):961-5. PubMed ID: 12130509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
    Klitgaard JL; Koefoed K; Geisler C; Gadeberg OV; Frank DA; Petersen J; Jurlander J; Pedersen MW
    Br J Haematol; 2013 Oct; 163(2):182-93. PubMed ID: 23927424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
    Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
    Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
    Kato Y; Kunita A; Fukayama M; Abe S; Nishioka Y; Uchida H; Tahara H; Yamada S; Yanaka M; Nakamura T; Saidoh N; Yoshida K; Fujii Y; Honma R; Takagi M; Ogasawara S; Murata T; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):20-24. PubMed ID: 28234556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
    Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells.
    Liu Y; Tian X; Jiang S; Ren X; Liu F; Yang J; Chen Y; Jiang Y
    Cell Immunol; 2015; 298(1-2):18-24. PubMed ID: 26300426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytotoxic action of monoclonal antibodies OC125 and SH-9 on ovarian cancer cell lines].
    Murakami F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):125-32. PubMed ID: 8718548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
    Meyer S; Leusen JH; Boross P
    MAbs; 2014; 6(5):1133-44. PubMed ID: 25517299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.